Research & KnowledgeEvent: September 3, 2026
MovaLife microrobotics published a recent review in Frontiers in Cell and Developmental Biology highlighting the analysis of microRNAs secreted by embryos into their culture environment for improving embryo selection in IVF.
Published
Signal category
Research & Knowledge
Quote
“A recent review published in Frontiers in Cell and Developmental Biology highlights a promising new avenue for improving embryo selection in IVF: the analysis of microRNAs (miRNAs) secreted by embryos into their culture environment.”
— Eric Lameignere|MovaLife microrobotics team
Company
MovaLife microrobotics
Creating IVF technologies for the future
- Industry
- Medical Equipment Manufacturing
- Location
- Paris, FR
- Company size
- 11 employees
MovaLive microrobotics aims to bring about a transition in the field of Assisted Reproductive Technology (ART) from its current state of near-artisanal to Industry 4.0 through automation, robotics, and operator assistance. Our goal is to provide access to In Vitro Fertilization (IVF) to a larger number of people, at the best cost, and with the highest chances of success.